Views & Analysis Words, inclusivity, and the struggle for health equality Outdated or offensive terminology can reinforce barriers to clinical trial participation and accessible healthcare.
Views & Analysis It’s time for new language in healthcare marketing Healthcare brands need some new terminology and new models.
News ASCO: Novartis touts Kisqali adjuvant breast cancer data Novartis looks odds on to extend the indications of its CDK4/6 inhibitor Kisqali into early-stage breast cancer, on the back of data from the phase 3 NATALEE trial reporte
R&D Inside the new world of healthcare data These days, real-world data collection is in vogue and not hard to come by in healthcare research.